Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.


Here you will find information and news about the latest events. In this way, you can stay ‘a heartbeat ahead’
of developments.

Also available as RSS feed for your RSS feed reader.

You can subscribe to our newsletter here:

Sudden Cardiac Arrest – Doc Fischer talks about CARL. in SWR-TV

It can happen to anyone at any time. Sudden cardiac arrest. The SWR-health programme ‘Doc Fischer’ explains the causes of sudden cardiac arrest, patient prevention possibilities and how the new second-line therapy CARL might improve survival rates further, both in- and out-of-hospital.

Image: SWR

Learn more >
CARL. receives the German Business Award 2023

Resuscitec GmbH is one of the 2023 winners of the German Business Awards at EU Business News.

Learn more >
CARL. Resuscitec awarded with the Lothar Späth Award 2023

Yesterday, Thursday evening, November 16, 2023, Resuscitec, represented by our management Prof. Benk, Mr. Ronde and Dr. Kraft, together with our cooperation partner from the Medical Center – University of Freiburg, represented by Prof. Beyersdorf, received the 1st prize of the Lothar Späth Award 2023 in the Zeiss Planetarium Jena.

Learn more >
Resuscitec selected to be one of the ‘Top 10 MedTech Startups in Europe 2023’

MedTech Outlook Magazine is an international medical technology magazine with over 132,300 subscribers across Europe. Each year, the European edition of the magazine shortlists 10 companies to be part of the ‘Top 10 MedTech Startups in Europe’.

Learn more >
EACTS 2023 – CARL. Raising the bar of ECPR

At the 37th EACTS Annual Meeting, which took place in Vienna from October 4 – 7 under the slogan “Raising the Bar ­– Innovate, Discover, Educate”, we experienced a significant increase in the number of physicians, perfusionists, distributors and partners compared to the previous year. This indicates that the CARL Community is growing rapidly.

Learn more >
1st Summit

On September 15 and 16, CARL Academy welcomed over 100 European ECPR and CARL experts to the first edition of the CARL Summit in Freiburg, Germany. In many inspiring presentations and discussions, the leading key opinion leaders in the field shared their expertise, recent experiences and tips and tricks for the successful realization of ECPR programs. An important step to shape the future of ECPR.

Learn more >
Family man survives thanks to CARL.

Jörg Teichfischer suffered a cardiac arrest at home in spring 2023. He was resuscitated by an emergency physician by means of defibrillator and cardiac massage for 55 minutes. Afterwards an ambulance took him to the Ortenau Klinikum Lahr, where resuscitative measures continued for almost 20 minutes.

Learn more >
Retiree back to life after cardiac arrest

Retiree back to life after cardiac arrest Our drive is to save lives and give patients suffering a cardiac arrest the chance to survive neurologically intact – anywhere in the world, in- and out-of-hospital. Our system joins the rescue chain and is being applied when, despite of all efforts, the heart cannot be restarted with…

Learn more >
31-year-old man survives cardiac arrest without neurological sequelae

In Europe, around 500,000 people suffer a sudden cardiac arrest every year. Outside of a hospital, only about 8% of those affected survive, and a high percentage of survivors suffer from neurological sequelae after resuscitation.

Learn more >
The CARL-Mobil in the rescue chain of Freiburg

When an emergency call is received at the integrated control center in Freiburg and a cardiac arrest, a secured resuscitation or a drowning accident is reported, the CARL-Mobil is alerted directly in addition to an ambulance and an emergency medical service vehicle. The concept of parallel alerting thus saves valuable minutes and shortens the time until the arrival of the treatment team.

Learn more >